title: Anesthetic considerations in Netherton Syndrome.
authors.forename: Hubert
authors.initials: H
authors.lastname: Benzon
authors.forename: Jennifer
authors.initials: J
authors.lastname: Thompson
authors.forename: Heather
authors.initials: H
authors.lastname: Nardone
authors.forename: Laurie
authors.initials: L
authors.lastname: Ohlms
authors.forename: Trevor
authors.initials: T
authors.lastname: McGill
authors.forename: Robert S
authors.initials: RS
authors.lastname: Holzman
mesh_terms: D000758:Anesthesia; D000771:Anesthesia, Intravenous; D000778:Anesthetics, Dissociative; D018686:Anesthetics, Intravenous; D002571:Cerumen; D016057:Evoked Potentials, Auditory, Brain Stem; D005260:Female; D006024:Glycopyrrolate; D006801:Humans; D007223:Infant; D007641:Keratolytic Agents / Q000627:therapeutic use; D007649:Ketamine; D008874:Midazolam; D016343:Monitoring, Intraoperative; D018727:Muscarinic Antagonists; D056770:Netherton Syndrome / Q000150:complications*; D015742:Propofol; D012867:Skin / Q000473:pathology; D014708:Vernix Caseosa
chemical_list: D000778:Anesthetics, Dissociative; D018686:Anesthetics, Intravenous; D007641:Keratolytic Agents; D018727:Muscarinic Antagonists; D007649:Ketamine; D008874:Midazolam; D006024:Glycopyrrolate; D015742:Propofol